Global Drug Delivery Partnering 2010-2018: Deal Trends, Players and Financials of 1,800 Online Deal Records - ResearchAndMarkets.com

DUBLIN--()--The "Global Drug Delivery Partnering 2010-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

The Global Drug Delivery Partnering 2010-2018 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

The report takes the reader through a comprehensive review Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Drug Delivery partnering deals.

The report presents financial deal term values for Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

One of the key highlights of the report is that over 1,800 online deal records of actual Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

Key benefits

  • In-depth understanding of Drug Delivery deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Drug Delivery agreements with numerous real life case studies
  • Detailed access to actual Drug Delivery contracts entered into by leading biopharma companies
  • Identify most active Drug Delivery dealmakers since 2010
  • Insight into terms included in a Drug Delivery partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

  • Trends in Drug Delivery dealmaking in the biopharma industry since 2010
  • Analysis of Drug Delivery deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life Drug Delivery deals
  • Access to Drug Delivery contract documents
  • Leading Drug Delivery deals by value since 2010
  • Most active Drug Delivery dealmakers since 2010

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Drug Delivery dealmaking

Chapter 3 - Leading Drug Delivery deals

Chapter 4 - Most active Drug Delivery dealmakers

Chapter 5 - Drug Delivery contracts dealmaking directory

Chapter 6 - Drug Delivery dealmaking by technology type

Chapter 7 - Partnering resource center

For more information about this report visit https://www.researchandmarkets.com/research/29kwlm/global_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery